Positive-strand RNA viruses exist as a quasi-species due to the incorporation of mutations into the viral genome during replication by the virus-encoded RNA-dependent RNA polymerase (RdRP). Therefore, the RdRP is often described as a low-fidelity enzyme. However, until recently, a complete description of the kinetic, thermodynamic and structural basis for the nucleotide incorporation fidelity of the RdRP has not been available. In this article, we review the following: (i) the steps employed by the RdRP to incorporate a correct nucleotide; (ii) the steps that are employed by the RdRP for nucleotide selection; (iii) the structure-based hypothesis for nucleotide selection; (iv) the impact of sites remote from the active site on polymerase fidelity. Given the recent observation that RNA viruses exist on the threshold of error catastrophe, the studies reviewed herein suggest novel strategies to perturb RdRP fidelity that may lead ultimately to the development of antiviral agents to treat RNA virus infection.
Positive-strand RNA viruses exist as a quasi-species due to the incorporation of mutations into the viral genome during replication by the virus-encoded RNA-dependent RNA polymerase (RdRP). Therefore, the RdRP is often described as a low-fidelity enzyme. However, until recently, a complete description of the kinetic, thermodynamic and structural basis for the nucleotide incorporation fidelity of the RdRP has not been available. In this article, we review the following: (i) the steps employed by the RdRP to incorporate a correct nucleotide; (ii) the steps that are employed by the RdRP for nucleotide selection; (iii) the structure-based hypothesis for nucleotide selection; (iv) the impact of sites remote from the active site on polymerase fidelity. Given the recent observation that RNA viruses exist on the threshold of error catastrophe, the studies reviewed herein suggest novel strategies to perturb RdRP fidelity that may lead ultimately to the development of antiviral agents to treat RNA virus infection.
Positive-strand RNA viruses cause a number of human diseases, including the common cold, myocarditis, hepatitis and severe acute respiratory syndrome (SARS). Treatment of RNA virus infection has proven to be a challenging task. However, even if effective therapeutics existed, the quasi-species nature of RNA viruses would facilitate the emergence of virus variants that are resistant to antiviral therapy.The variability displayed in RNA virus populations can be attributed to mutations introduced into the genome by the viral replicase during each round of replication. The viral replication machinery is a complex assembly of viral, and in some cases, host proteins. However, at the heart of the replication machinery is the virus-encoded RNA-dependent RNA polymerase (RdRP). RdRPs have been shown to display a high mutation rate compared to their DNA counterparts (Drake, 1993, Drake, 1999). This decrease in fidelity exhibited by RdRPs has been suggested to be the primary contributing factor for the variability in RNA virus genomes.Numerous studies have documented the high mutation frequency exhibited by RNA viruses as well as their rapid rates of evolution (De la Torre et al., 1990, Domingo, 1989, Domingo et al., 1985, Domingo et al., 1996, Drake, 1993, Drake, 1999, Drake and Holland, 1999, Holland et al., 1982, Holland et al., 1990). The determination of RNA virus mutation frequencies has been accomplished by evaluating the following: (i) development of resistance to antiviral agents; (ii) escape from monoclonal antibody treatment; (iii) changes in virus fitness; (iv) serial passage of the virus in cell culture or in vivo followed by direct sequencing (Table 1
). Unfortunately, mutations that produce replication-incompetent or perhaps translation-incompetent genomes are not scored in these assays. Therefore, direct measurements of the intrinsic error rate of the RdRP obtained from in vitro analysis is the simplest approach to define the upper limit for the mutational frequency of a RNA virus.
Table 1
Mutation frequenciesa of selected RNA viruses
Virus
Mutation frequency
Assay
References
PV-1
5.4 × 10−3–7 × 10−4
Biochemical assayb
Ward et al. (1988)
PV-1
2.1 × 10−4
GuaD–GuaRc
De la Torre et al. (1990)
PV-1
7.8 × 10−5–4 × 10−8
GuaD–GuaR
Pincus et al. (1986)
Coxsackie A9
1 × 10−4
2-HBB resistanced
Eggers and Tamm (1965)
Influenza A
1.5 × 10−5
Plaque assaye
Parvin et al. (1986)
VSV
1 × 10−3–1 × 510−4
Plaque assay
Steinhauer et al. (1989)
PV-1
2.1 × 10−4
Sequencingf
Crotty et al. (2001)
HAV
1 × 10−3–1 × 10−4
Sequencing
Sanchez et al. (2003)
TMV
3 × 10−4
Sequencing
Kearney et al. (1999)
HCV
∼1 × 10−3
Sequencing
Young et al. (2003)
FMDV
1.4 × 10−4
Sequencing
Airaksinen et al. (2003)
HTNV
1.1 × 10−3
Sequencing
Severson et al. (2003)
LCMV
3.6 × 10−4
Sequencing
Ruiz-Jarabo et al. (2003)
Mutation frequency is defined as the number of mutations per replication event.
Amount of a noncomplementary nucleotide incorporated divided by the total amount of complementary and noncomplementary nucleotide incorporated using homopolymeric RNA templates.
Reversion of guanidine dependant to guanidine resistant.
Development of resistance to 2-(α-hydroxybenzyl)-benzimidazole (2-HBB).
Mutations were determined by sequencing different plaques developed after infection with a single clone.
Viral population samples from the host organism or cell culture were isolated, amplified and sequenced.
Mutation frequenciesa of selected RNA virusesMutation frequency is defined as the number of mutations per replication event.Amount of a noncomplementary nucleotide incorporated divided by the total amount of complementary and noncomplementary nucleotide incorporated using homopolymeric RNA templates.Reversion of guanidine dependant to guanidine resistant.Development of resistance to 2-(α-hydroxybenzyl)-benzimidazole (2-HBB).Mutations were determined by sequencing different plaques developed after infection with a single clone.Viral population samples from the host organism or cell culture were isolated, amplified and sequenced.The genetic variability of RNA viruses is advantageous and allows viruses to adapt to environmental changes more rapidly; however, a consequence of this same genetic variability is the enhanced sensitivity of the viral population to accumulation of additional mutations (Holland et al., 1990, Irurzun et al., 1992, Lee et al., 1997). As the number of mutations in the viral genomes increases and passes this error threshold, the fitness decreases significantly, ultimately resulting in extinction. Therefore, agents that increase the mutation frequency of the virus should be effective antivirals. This prediction was confirmed by studies of ribavirin that showed that the mechanism of action of this antiviral agent is lethal mutagenesis (Crotty et al., 2001, Crotty et al., 2000).Given the importance of incorporation fidelity for the viability of RNA viruses and the potential to exploit small-molecule modulators of incorporation fidelity as antiviral agents, a precise description of the molecular basis for incorporation is warranted. In this article, we review the kinetic and thermodynamic analysis of correct and incorrect nucleotide incorporation catalyzed by the RdRP from poliovirus (3Dpol) highlighting the steps that are essential for nucleotide substrate selection. In addition, we review the structure-based hypothesis for 3Dpol fidelity that likely extends to all animal virus RdRPs.
Kinetic mechanism of nucleotide incorporation for poliovirus 3Dpol
In order to establish a system to preclude heterogeneous binding of 3Dpol to primer/template, thereby permitting mechanistic analysis, a novel substrate was designed (Fig. 1
) (Arnold and Cameron, 2000). This RNA substrate consists of a 10-nucleotide heteropolymeric RNA that is self-complementary and forms a six base-pair duplex region with an identical 4-nucleotide 5′-overhang on both sides of the primer/template. Both 3′-hydroxyls of the substrate are competent for templated extension resulting in a symmetrical substrate, termed sym/sub (Arnold and Cameron, 2000) (Fig. 1). The enzyme binds productively to sym/sub regardless of the orientation of binding and regardless of which of the two 3′-hydroxyls is in the catalytic center. The 4-nucleotide template permits either single or multiple rounds of nucleotide incorporation to be evaluated by selecting the appropriate nucleotide or nucleotides employed in the reaction. 3Dpol–sym/sub complexes recapitulate a biologically relevant elongation complex (Gohara et al., 2000); therefore, analysis of the mechanism of nucleotide incorporation in vitro using this substrate is likely to be relevant to the reaction in vivo.
Fig. 1
Symmetrical primer template substrate (sym/sub) used to study poliovirus polymerase 3Dpol-catalyzed nucleotide incorporation.
Symmetrical primer template substrate (sym/sub) used to study poliovirus polymerase 3Dpol-catalyzed nucleotide incorporation.Evaluation of the kinetics of nucleotide incorporation into sym/sub by 3Dpol has revealed information on the binding of the incoming nucleotide, the maximal rate of nucleotide incorporation and the specificity of nucleotide incorporation (Table 2
). These parameters are expressed by the kinetic constants: K
d,app, k
pol and k
pol/K
d,app, respectively (Arnold and Cameron, 2004b). The fidelity of the viral RdRP can be obtained by comparing k
pol/K
d,app values for correct and incorrect nucleotides. A complete kinetic and thermodynamic analysis of poliovirus 3Dpol-catalyzed nucleotide incorporation revealed that nucleotide incorporation can be described by the five steps shown in Scheme 1
(Arnold and Cameron, 2004b). The 3Dpol–sym/sub complex (ER) binds nucleotide (NTP) to form a ternary complex (ERNTP) that undergoes a conformational change to form a complex that is competent for phosphoryl transfer (*ERNTP). Chemistry occurs, forming a ternary product complex (*ERPP); this complex isomerizes to form a ternary product complex (ERPP) from which PP can dissociate. After dissociation of PP, a 3Dpol–sym/sub product complex (ER) remains that is competent for the next cycle of nucleotide incorporation. For poliovirus 3Dpol, two steps in the mechanism are partially rate-limiting for correct nucleotide incorporation: the conformational-change step (step 2) prior to phosphoryl transfer and the phosphoryl-transfer step (step 3) (Arnold and Cameron, 2004b).
Table 2
Kinetic parameters for 3Dpol-catalyzed nucleotide incorporation
Substrates
Kinetic parameters
Fidelitya
Nucleic acid
Nucleotide
Kd,app (μM)
kpol (s−1)
kpol/Kd (μM−1 s−1)
sym/sub-U
GCAUGGGCCC
ATP
134 ± 18
87 ± 4
0.65
–
CCCGGGUACG
2′-dATP
284 ± 59
0.80 ± 0.06
2.8 × 10−3
230
3′-dATP
317 ± 51
1.4 ± 0.1
4.4 × 10−3
150
CTP
>500 μM
<0.0025 s−1
<5 × 10−6
>2.0 × 105
GTP
430 ± 98
0.014 ± 0.003
3.3 × 10−5
2.3 × 104
UTP
>500 μM
<0.0025 s−1
<5 × 10−6
>2.0 × 105
Fidelity is calculated as [(kpol/Kd,app)ATP + (kpol/Kd,app)incorrect]/[(kpol/Kd,app)incorrect] (Patel et al., 1991), reproduced with permission from Biochemistry.
Scheme 1
Complete kinetic mechanism for 3Dpol-catalyzed nucleotide incorporation.
Kinetic parameters for 3Dpol-catalyzed nucleotide incorporationFidelity is calculated as [(kpol/Kd,app)ATP + (kpol/Kd,app)incorrect]/[(kpol/Kd,app)incorrect] (Patel et al., 1991), reproduced with permission from Biochemistry.Complete kinetic mechanism for 3Dpol-catalyzed nucleotide incorporation.The kinetic and thermodynamic analysis of correct nucleotide incorporation described above has been interpreted by using the structural model for the 3Dpol–sym/sub–ATP complex illustrated in Fig. 2
. Binding of the incoming nucleotide in complex with divalent cation to the 3Dpol–primer/template complex is driven by the metal-complexed triphosphate moiety of the nucleotide (Fig. 2A). Once bound, a conformational change occurs to bring the metal-complexed triphosphate moiety into the appropriate position to interact with the conserved aspartyl groups of the enzyme, and at the same time, organizes the active site for acceptance of the second metal ion required for catalysis (Fig. 2B). Finally, catalysis occurs (Fig. 2C).
Kinetic basis for fidelity of nucleotide incorporation
It has been well documented that substitution of Mn2+ for Mg2+ as the divalent cation cofactor in polymerase-catalyzed reactions decreases the stringency of substrate selection and incorporation fidelity (Arnold et al., 1999, Beckman et al., 1985, Goodman et al., 1983, Huang et al., 1997, Liu and Tsai, 2001, Tabor and Richardson, 1989). However, the detailed mechanistic basis for the destructive effects of Mn2+ was not completely understood until recently (Arnold et al., 2004). By using Mn2+ as the divalent cation cofactor, the ability to diminish the rate of phosphoryl transfer for incorrect nucleotides relative to correct nucleotides is lost completely, leaving only the conformational-change step for nucleotide selection (Scheme 2
) (Arnold et al., 2004). When Mn2+ is employed as the divalent cation, the conformation of the metal-bound triphosphate coupled with the additional adventitious interactions that can occur between the enzyme and Mn2+ increases the stability of the activated ternary complex (Scheme 2, step 2). Compared to reactions in the presence of Mg2+, the increase in stability of the activated ternary complex is the same regardless of the nature of the nucleotide (correct or incorrect). In addition, the capacity of Mn2+ to bind more tightly to the β and γ phosphates makes the orientation of the triphosphate independent of interactions with residues in the ribose-binding pocket. Consequently, perturbations in the orientation of the triphosphate will not occur in response to binding of a nucleotide with an incorrect base or sugar configuration. Therefore, the inability to couple the nature of the bound nucleotide to the efficiency of phosphoryl transfer is the primary reason for the observed loss of 3Dpol fidelity in the presence of Mn2+.
Scheme 2
Comparison of the conformational-change step and the phosphoryl-transfer step for 3Dpol-catalyzed correct and incorrect nucleotide incorporation in the presence of Mg2+ and Mn2+.
Comparison of the conformational-change step and the phosphoryl-transfer step for 3Dpol-catalyzed correct and incorrect nucleotide incorporation in the presence of Mg2+ and Mn2+.Given that the conformational-change step (step 2) and the phosphoryl-transfer step (step 3) are partially rate-limiting for correct nucleotide incorporation, it was likely that these two steps were used to maximize polymerase fidelity. Restated, these two steps would be used by the enzyme to distinguish a correct nucleotide from an incorrect nucleotide. Through evaluation of the differences between correct and incorrect nucleotide incorporation catalyzed by 3Dpol, it was found that there is no difference in ground-state binding (step 1) regardless of the nucleotide substrate employed (Table 2, Fig. 3
). Therefore, ground-state binding cannot contribute to the process of nucleotide substrate selection. The reason for this observation likely reflects the use of the triphosphate for ground-state binding instead of the ribose or base. However, the two steps in the kinetic mechanism for nucleotide incorporation catalyzed by 3Dpol that provide the greatest contribution to fidelity are formation of the activated ternary complex (step 2) and phosphoryl transfer (step 3) (Scheme 1, Scheme 2, Fig. 3).
Sequence alignments of animal virus RdRPs have indicated the presence of several absolutely conserved amino acid residues that can be mapped to the nucleotide-binding pocket (Gohara et al., 2000, Gohara et al., 2004, Hansen et al., 1997, Koonin, 1991). Six of these interact with the nucleotide substrate: Asp-233, Asp-238, Asp-328, Ser-288, Thr-293, and Asn-297 (Fig. 5A). In order to determine the importance of these residues for nucleotide selection, 3Dpol derivatives were created in which some of these residues were changed to alanine. The derivatives were subsequently purified and the mechanism of nucleotide selection determined by evaluating the kinetics of incorporation of correct and incorrect nucleotides (Gohara et al., 2000, Gohara et al., 2004).
Amino acid residues at remote sites also contribute to RdRP fidelity
Recently, a poliovirus variant with decreased sensitivity to ribavirin was isolated (Pfeiffer and Kirkegaard, 2003). This poliovirus variant encodes a polymerase with a change of Gly-64 to Ser (G64S) mutation in the fingers subdomain (Pfeiffer and Kirkegaard, 2003). Analysis of the mutation frequency of the G64S virus by using a guanidine-resistance assay indicated that the G64S polymerase had an increase in incorporation fidelity.The fidelity of the G64S3Dpol has been evaluated by analyzing the incorporation of AMP, GMP and RMP (ribavirin) into sym/sub (Table 3
) (Arnold and Cameron, 2004a). Nucleotide binding by G64S3Dpol is equivalent to wild-type 3Dpol regardless of the nature of the nucleotide, correct or incorrect, consistent with the finding that binding is governed primarily by the triphosphate moiety (Table 3). However, the overall efficiency of RMP and GMP incorporation was reduced significantly relative to wild-type 3Dpol, suggesting a decrease in either the conformational-change step or the phosphoryl-transfer step (Table 3). The fidelity of G64S3Dpol increased compared to wild-type enzyme, and the capacity of the G64S substitution to permit decreased utilization of RTP could be explained by increased fidelity of this derivative relative to wild-type 3Dpol. The mechanistic basis for this increased fidelity is a change in the stability of the activated ternary complex compared to wild-type 3Dpol (Arnold and Cameron, 2004a). The ability to show that an amino acid substitution in 3Dpol that increases polymerase fidelity causes a change in step 2 (Scheme 1) provides an undisputable link between this step and fidelity (Showalter and Tsai, 2002).
Table 3
Kinetic parameters for wild-type and G64S 3Dpol-catalyzed nucleotide incorporation
Enzyme
Nucleotide
Kinetic parameters
Fidelitya
Kd,app
kpol (s−1)
kpol/Kd (μM−1 s−1)
WT
ATP
134 ± 18
87 ± 4
0.65
–
RTP
386 ± 42
0.011 ± 0.003
2.8 × 10−5
2.3 × 104
GTP
430 ± 98
0.014 ± 0.001
3.3 × 10−5
2.0 × 104
G64S
ATP
161 ± 10
32 ± 2
0.20
–
RTP
367 ± 43
0.0021 ± 0.0002
5.7 × 10−6
3.5 × 104
GTP
444 ± 66
0.0035 ± 0.0002
7.9 × 10−6
2.5 × 104
Fidelity is calculated as [(kpol/Kd,app)ATP + (kpol/Kd,app)incorrect]/[(kpol/Kd,app)incorrect] (Patel et al., 1991).
Kinetic parameters for wild-type and G64S3Dpol-catalyzed nucleotide incorporationFidelity is calculated as [(kpol/Kd,app)ATP + (kpol/Kd,app)incorrect]/[(kpol/Kd,app)incorrect] (Patel et al., 1991).The structural basis for the increased fidelity observed for G64S3Dpol is not currently known and may be difficult to discern, given the subtle difference in fidelity relative to wild-type and the lack of available RdRP co-crystal structures with RNA primer/template and nucleotide bound. The Gly-64 residue is located in the fingers domain (Fig. 7
) of the polymerase, and it is not possible to suggest a direct mechanism for interaction with the nucleotide substrate given its remote location.
Fig. 7
Location of Gly-64 in the structural model of 3Dpol. Model of 3Dpol (complete) based upon sequence and structural homology to rabbit hemorrhagic disease virus 3Dpol (Ng et al., 2002). The conserved structural motifs in the palm subdomain are colored as follows: motif A, red; motif B, green; motif C, yellow; motif D, blue; motif E, purple. van der Waal's projection of Gly-64 (orange). The image was rendered using the program WebLab Viewer Pro (Molecular Simulations Inc., San Diego, CA).
Location of Gly-64 in the structural model of 3Dpol. Model of 3Dpol (complete) based upon sequence and structural homology to rabbit hemorrhagic disease virus3Dpol (Ng et al., 2002). The conserved structural motifs in the palm subdomain are colored as follows: motif A, red; motif B, green; motif C, yellow; motif D, blue; motif E, purple. van der Waal's projection of Gly-64 (orange). The image was rendered using the program WebLab Viewer Pro (Molecular Simulations Inc., San Diego, CA).
Implications of the kinetic, thermodynamic and structural basis for RdRP fidelity on the development of antivirals
The discovery that residues remote from the ribose-binding pocket can modulate fidelity is quite provocative. It is conceivable that small molecules can be developed that bind to surfaces of the polymerase and modulate fidelity. Compounds that increase incorporation fidelity should make the virus more susceptible to pressures that could be evaded by population diversity, for example, the immune system. Compounds that decrease incorporation fidelity should force the virus into error catastrophe. Clearly, this strategy will prevent the complications associated with nucleoside-based polymerase inhibitors. Importantly, these small molecules can be “recycled” in a mechanism in which the antiviral would bind to the activated ternary complex, altering its fidelity and then be released.
Authors: Philip J Gerrish; Alexandre Colato; Alan S Perelson; Paul D Sniegowski Journal: Proc Natl Acad Sci U S A Date: 2007-04-03 Impact factor: 11.205
Authors: Jussi J Joensuu; Andrew J Conley; Michael Lienemann; Jim E Brandle; Markus B Linder; Rima Menassa Journal: Plant Physiol Date: 2009-12-11 Impact factor: 8.340